A01K 2227/00
Animals characterised by species
A01K2227/00 (Animals characterised by species) appears on 4,519 US grants and 8,946 published applications in this corpus.
Search patents in A01K- Granted patents
- 4,519
- Published applications
- 8,946
- Assignees
- 2,709
- Inventors
- 14,651
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 7 | 0 |
| 1993 | 4 | 0 |
| 1994 | 8 | 0 |
| 1995 | 10 | 0 |
| 1996 | 40 | 0 |
| 1997 | 68 | 0 |
| 1998 | 107 | 0 |
| 1999 | 111 | 0 |
| 2000 | 105 | 0 |
| 2001 | 119 | 23 |
| 2002 | 81 | 258 |
| 2003 | 114 | 814 |
| 2004 | 89 | 315 |
| 2005 | 75 | 356 |
| 2006 | 129 | 380 |
| 2007 | 151 | 293 |
| 2008 | 160 | 281 |
| 2009 | 141 | 302 |
| 2010 | 154 | 324 |
| 2011 | 128 | 296 |
| 2012 | 132 | 231 |
| 2013 | 145 | 245 |
| 2014 | 129 | 240 |
| 2015 | 169 | 282 |
| 2016 | 151 | 303 |
| 2017 | 175 | 297 |
| 2018 | 170 | 318 |
| 2019 | 172 | 404 |
| 2020 | 192 | 476 |
| 2021 | 209 | 488 |
| 2022 | 205 | 502 |
| 2023 | 221 | 436 |
| 2024 | 220 | 444 |
| 2025 | 246 | 394 |
| 2026 | 176 | 244 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Method for producing genetically edited birds having resistance to avian influenza viruses22 Sep 2026US 12,742,180 B2Seoul National University R&Db Foundation
- Non-viral transgenesis15 Sep 2026US 12,735,719 B2The Regents of the University of California
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Feed intake monitoring device and system based on pressure sensing during cattle jaw movement1 Oct 2026US 2026/0293857 A1Information Technology Research Center, Beijing Academy of Agriculture and Forestry Sciences
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996